Mereo BioPharma Group (MREO) Short Interest Ratio & Short Volume → See this before next week's Fed meeting (From Stansberry Research) (Ad) Free MREO Stock Alerts $2.76 -0.02 (-0.72%) (As of 11:35 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Mereo BioPharma Group Short Interest DataCurrent Short Volume2,770,000 sharesPrevious Short Volume2,330,000 sharesChange Vs. Previous Month+18.88%Dollar Volume Sold Short$7.40 millionShort Interest Ratio / Days to Cover1.8Last Record DateApril 15, 2024Outstanding Shares124,986,000 sharesPercentage of Shares Shorted2.22%Today's Trading Volume388,162 sharesAverage Trading Volume1,576,736 sharesToday's Volume Vs. Average25% Short Selling Mereo BioPharma Group ? Sign up to receive the latest short interest report for Mereo BioPharma Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMREO Short Interest Over TimeMREO Days to Cover Over TimeMREO Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Mereo BioPharma Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,770,000 shares $7.40 million +18.9%N/A1.8 $2.67 3/31/20242,330,000 shares $7.69 million +6.4%N/A1.3 $3.30 3/15/20242,190,000 shares $6.81 million -1.8%N/A1.3 $3.11 2/29/20242,230,000 shares $8.47 million -19.8%N/A1.4 $3.80 2/15/20242,780,000 shares $10.26 million +25.8%N/A1.8 $3.69 1/31/20242,210,000 shares $8.38 million +59.0%N/A1.5 $3.79 Get the Latest News and Ratings for MREO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mereo BioPharma Group and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,390,000 shares $4.10 million -6.1%N/A1.1 $2.95 12/31/20231,480,000 shares $3.42 million -18.2%N/A1.1 $2.31 12/15/20231,810,000 shares $3.71 million -33.9%N/A1.4 $2.05 11/30/20232,740,000 shares $5.73 million -3.5%N/A2.2 $2.09 11/15/20232,840,000 shares $6.25 million -20.9%N/A2.3 $2.20 10/31/20233,590,000 shares $7.20 million +13.6%N/A2.9 $2.01 10/15/20233,160,000 shares $4.08 million +4.6%N/A2.6 $1.29 9/30/20233,020,000 shares $3.90 million -15.2%N/A3.5 $1.29 9/15/20233,560,000 shares $5.55 million -26.6%N/A3.9 $1.56 8/31/20234,850,000 shares $6.64 million -19.0%N/A4.4 $1.37 8/15/20235,990,000 shares $7.55 million -3.4%N/A3.7 $1.26 7/31/20236,200,000 shares $8.25 million -19.5%N/A3.4 $1.33 7/15/20237,700,000 shares $9.63 million -26.9%N/A3.8 $1.25 6/30/202310,530,000 shares $13.90 million +11.2%N/A5.3 $1.32 6/15/20239,470,000 shares $13.54 million +14.8%N/A4.8 $1.43 5/31/20238,250,000 shares $8.33 million +59.9%N/A4.5 $1.01 5/15/20235,160,000 shares $6.45 million +22.0%N/A3.8 $1.25 4/30/20234,230,000 shares $5.54 million +8.5%N/A3.6 $1.31 4/15/20233,900,000 shares $4.10 million +2.4%N/A3.9 $1.05 3/31/20233,810,000 shares $2.69 million -0.5%N/A4.3 $0.71 3/15/20233,830,000 shares $3.26 million +15.4%N/A4.2 $0.85 2/28/20233,320,000 shares $2.96 million -16.4%N/A3.8 $0.89 2/15/20233,970,000 shares $4.41 million +12.2%N/A4.4 $1.11 1/31/20233,540,000 shares $3.31 million -4.6%N/A4.9 $0.94 1/15/20233,710,000 shares $3.29 million +6.3%N/A5.5 $0.89 12/30/20223,490,000 shares $2.62 million -27.4%N/A5.9 $0.75 12/15/20224,810,000 shares $3.67 million -3.0%N/A9.4 $0.76 11/30/20224,960,000 shares $3.91 million -2.8%N/A11.5 $0.79 11/15/20225,100,000 shares $4.04 million -10.7%N/A11 $0.79 10/31/20225,710,000 shares $5.71 million -6.2%N/A8.8 $1.00 10/15/20226,090,000 shares $6.09 million -5.3%N/A7.7 $1.00 9/30/20226,430,000 shares $5.54 million -4.7%N/A5.8 $0.86 9/15/20226,750,000 shares $7.22 million -3.9%N/A3.9 $1.07 8/31/20227,020,000 shares $8.42 million +11.3%6.5%1.4 $1.20See this before next week's Fed meeting (Ad)See this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.) Click here to see it. MREO Short Interest - Frequently Asked Questions What is Mereo BioPharma Group's current short interest? Short interest is the volume of Mereo BioPharma Group shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 2,770,000 shares of MREO short. Learn More on Mereo BioPharma Group's current short interest. What is a good short interest ratio for Mereo BioPharma Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MREO shares currently have a short interest ratio of 2.0. Learn More on Mereo BioPharma Group's short interest ratio. Is Mereo BioPharma Group's short interest increasing or decreasing? Mereo BioPharma Group saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,770,000 shares, an increase of 18.9% from the previous total of 2,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mereo BioPharma Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Mereo BioPharma Group: Precigen, Inc. (13.01%), UroGen Pharma Ltd. (17.91%), Rani Therapeutics Holdings, Inc. (14.69%), Amarin Co. plc (3.86%), Harrow Health, Inc. (16.74%), Atai Life Sciences (5.11%), Nature's Sunshine Products, Inc. (0.63%), Nkarta, Inc. (11.27%), PepGen Inc. (1.25%), Atea Pharmaceuticals, Inc. (2.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Mereo BioPharma Group stock? Short selling MREO is an investing strategy that aims to generate trading profit from Mereo BioPharma Group as its price is falling. MREO shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mereo BioPharma Group? A short squeeze for Mereo BioPharma Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MREO, which in turn drives the price of the stock up even further. How often is Mereo BioPharma Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MREO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Precigen Short Squeeze UroGen Pharma Short Squeeze Rani Therapeutics Short Squeeze Amarin Short Squeeze Harrow Health Short Squeeze Atai Life Sciences Short Squeeze Nature's Sunshine Products Short Squeeze Nkarta Short Squeeze PepGen Short Squeeze Atea Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MREO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsYour Money is Not SafeAmerican Alternativetop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press